期刊
DIABETES
卷 57, 期 5, 页码 1387-1393出版社
AMER DIABETES ASSOC
DOI: 10.2337/db07-1217
关键词
-
资金
- NEI NIH HHS [K08 EY016833, R01 EY000300, R01EY00300, K08EY16833, P30 EY011373, P30EY11373] Funding Source: Medline
- NHLBI NIH HHS [HL PO1 55798] Funding Source: Medline
OBJECTIVE-Lipoxygenases are regulators of chronic inflamation and oxidative stress generation. We evaluated the role of 5-and 12-lipoxygenases in the development of diabetic retinopathy. RESEARCH DESIGN AND METHODS-Wild-type mice, 5-li-poxygenase- deficient mice, and 12/15-lipoxygenase- deficient mice were assessed 1) after 9 months of diabetes for retinal histopathology and leukotriene receptor expression and 2) after 3 months of diabetes for leukostasis and retinal superoxide generation. RESULTS-Diabetic wild-type mice developed the expected degeneration of retinal capillaries and pericytes and increases in both leukostasis and superoxide production (P < 0.006). We found no evidence of diabetes-induced degeneration of retinal ganglion cells in these animals. The vascular histopathology was significantly inhibited in 5-li-poxygenase- deficient mice, but not in 12/15-lipoxygenase- deficient mice. Retinas from diabetic 5-li-poxygenase- deficient mice also had significantly less leukostasis, superoxide production, and nuclear factor-kappa B (NF-kappa B) expression (all P < 0.006), whereas retinas from diabetic 12/15-lipoxygenase- deficient mice had significantly less leukostasis (P < 0.005) but not superoxide production or NF-kappa B expression. Retinas from diabetic wild-type mice were enriched with receptors for the 5-lipoxygenase metabolite leukotriene B-4. Diabetes-induced histological and biochemical alterations were significantly reduced in 5-li-poxygenase- deficient mice, but not 12/15-lipoxygenase- deficient mice. CONCLUSIONS-5-Lipoxygenase represents a novel pathway for therapeutic intervention of diabetic retinopathy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据